drugset / Trial / NCT01756430
Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of present study is to evaluate the efficacy and safety of Carvedilol SR versus Carvedilol IR in Patients With Essential Hypertension
Timeline
- Start
- 2012-12
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 25 mg | — |
| Subject | Carvedilol | Other / unclassified | 64 mg | — |